ORI
Oak Ridge Investments Portfolio holdings
AUM
$1.39B
1-Year Return
33.33%
This Quarter Return
+5.74%
1 Year Return
+33.33%
3 Year Return
+165.84%
5 Year Return
+254.68%
10 Year Return
+830.04%
AUM
$1.15B
AUM Growth
+$97.2M
(+9.3%)
Cap. Flow
+$57.5M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
51.15%
Holding
166
New
20
Increased
63
Reduced
68
Closed
14
Top Buys
| 1 |
NVIDIA
NVDA
|
$12.8M |
| 2 |
Broadcom
AVGO
|
$10.2M |
| 3 |
Microsoft
MSFT
|
$7.98M |
| 4 |
Apple
AAPL
|
$7.73M |
| 5 |
EXL Service
EXLS
|
$4.31M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$8.51M |
| 2 |
KLA
KLAC
|
$4.62M |
| 3 |
DexCom
DXCM
|
$3.93M |
| 4 |
Atkore
ATKR
|
$3.62M |
| 5 |
Alarm.com
ALRM
|
$3.58M |
Sector Composition
| 1 | Technology | 42.17% |
| 2 | Healthcare | 14.66% |
| 3 | Communication Services | 11.23% |
| 4 | Consumer Discretionary | 9.36% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Arthur J. Gallagher & Co
AJG
$77.6B
| $1.33M | 0.12% |
4,710
-108
| -2% | -$30.4K |
|
102
Qualcomm
QCOM
$170B
| $1.32M | 0.12% |
7,787
+39
| +0.5% | +$6.63K |
|
103
Ametek
AME
$43B
| $1.25M | 0.11% |
7,258
-3,547
| -33% | -$609K |
|
104
Axsome Therapeutics
AXSM
$6.1B
| $1.21M | 0.11% |
13,417
-519
| -4% | -$46.6K |
|
105
Remitly
RELY
$3.99B
| $1.2M | 0.1% |
89,847
-2,916
| -3% | -$39K |
|
106
Northern Oil and Gas
NOG
$2.53B
| $1.14M | 0.1% |
32,295
-1,252
| -4% | -$44.3K |
|
107
Regal Rexnord
RRX
$9.61B
| $1.09M | 0.1% |
6,589
-141
| -2% | -$23.4K |
|
108
Biohaven
BHVN
$1.67B
| $1.06M | 0.09% |
21,146
-854
| -4% | -$42.7K |
|
109
Ultragenyx Pharmaceutical
RARE
$3.02B
| $1.03M | 0.09% |
18,622
-728
| -4% | -$40.4K |
|
110
Amphenol
APH
$137B
| $1.01M | 0.09% |
15,534
-3,232
| -17% | -$211K |
|
111
UroGen Pharma
URGN
$896M
| $975K | 0.09% |
76,799
-3,130
| -4% | -$39.8K |
|
112
Watsco
WSO
$16.2B
| $952K | 0.08% |
1,936
-26
| -1% | -$12.8K |
|
113
Old Dominion Freight Line
ODFL
$30.6B
| $950K | 0.08% |
4,781
-99
| -2% | -$19.7K |
|
114
Cytokinetics
CYTK
$6B
| $938K | 0.08% |
17,771
-717
| -4% | -$37.9K |
|
115
CDW
CDW
$21.5B
| $931K | 0.08% |
4,113
-89
| -2% | -$20.1K |
|
116
Diamondback Energy
FANG
$41.1B
| $927K | 0.08% |
5,379
+21
| +0.4% | +$3.62K |
|
117
Idexx Laboratories
IDXX
$51.2B
| $906K | 0.08% |
1,794
-41
| -2% | -$20.7K |
|
118
GE HealthCare
GEHC
$33.4B
| $887K | 0.08% |
9,452
-203
| -2% | -$19.1K |
|
119
Vertex Pharmaceuticals
VRTX
$102B
| $850K | 0.07% |
1,827
+5
| +0.3% | +$2.33K |
|
120
Viking Therapeutics
VKTX
$2.92B
| $837K | 0.07% |
+13,222
| New | +$837K |
|
|
ITCI
121
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $833K | 0.07% |
11,391
-448
| -4% | -$32.8K |
|
122
Deckers Outdoor
DECK
$18.2B
| $829K | 0.07% |
5,202
-114
| -2% | -$18.2K |
|
123
W.W. Grainger
GWW
$49B
| $817K | 0.07% |
+786
| New | +$817K |
|
124
Prologis
PLD
$103B
| $801K | 0.07% |
6,340
+31
| +0.5% | +$3.92K |
|
125
Travere Therapeutics
TVTX
$1.77B
| $774K | 0.07% |
55,339
-2,245
| -4% | -$31.4K |
|